Daily MDOI Identifier Registry

Browse, search, and export all registered MDOI identifiers. Use the filters below to narrow results.

786 total identifiers
Reset
Export CSV
Showing 151–200 of 786
# Identifier Title Resource type Visibility Registered Modified
151 110.0676/CON.2026.00648
Inequality Aversion in Health: Eliciting Aversion to Univariate Health Inequalities Across Different Health Distributions
Article Public 2026-07-17 2026-07-17
152 110.0674/CON.2026.00646
The Impact of the Inflation Reduction Act’s Drug Price Negotiation Program on Incentives for Clinical Development of New Drugs
Article Public 2026-07-17 2026-07-17
153 110.0673/CON.2026.00645
Patient-Reported Outcomes Now and Into the Future: Multistakeholder Perspectives on Optimizing the Use of Patient-Reported Outcome Evidence in Decision Making Across the US Healthcare Continuum
Article Public 2026-07-17 2026-07-17
154 110.0672/CON.2026.00644
EQ Health and Wellbeing EQ-HWB: A Psychometric Assessment Across 6 Conditions and the General Population in the United Kingdom
Article Public 2026-07-17 2026-07-17
155 110.0671/CON.2026.00643
EQ Health and Wellbeing EQ-HWB: A Psychometric Assessment Across 6 Conditions and the General Population in the United Kingdom
Article Public 2026-07-17 2026-07-17
156 110.0670/CON.2026.00642
APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety
Article Public 2026-07-17 2026-07-17
157 110.0669/CON.2026.00641
Physician-Directed Reinvestment: A Novel Cost-Savings Framework for Hospital Systems That Leverages Frontline Physicians
Article Public 2026-07-17 2026-07-17
158 110.0668/CON.2026.00640
Zero Dollar Copay Pharmacy Benefit Decreases Healthcare Expenditures Among Members With Type 2 Diabetes of Blue Cross Blue Shield of Louisiana
Article Public 2026-07-17 2026-07-17
159 110.0667/CON.2026.00639
Poor Patient Care Outcomes and Nurse Job Outcomes Associated With Unfavorable Intensive Care Unit and Emergency Department Nurse Work Environments: Implications for Critical Care Medicine
Article Public 2026-07-17 2026-07-17
160 110.0666/CON.2026.00638
Measuring the First Mover Advantage in US Biosimilar Markets
Article Public 2026-07-17 2026-07-17
161 110.0665/CON.2026.00637
Methodological Challenges With Conducting Health Economic Evaluations in the Critical-Care Context
Article Public 2026-07-17 2026-07-17
162 110.0664/CON.2026.00636
Value-Based Commissioning of Mental Health Services in England: A Feasibility Study Using Multicriteria Decision Analysis
Article Public 2026-07-17 2026-07-17
163 110.0663/CON.2026.00635
Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme Trial: TPEx Versus EXTREME as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Article Public 2026-07-17 2026-07-17
164 110.0661/CON.2026.00633
Understanding the Role of Clinical and Functional Needs in Home-Visit Nursing Effectiveness: Evidence From South Korea
Article Public 2026-07-17 2026-07-17
165 110.0660/CON.2026.00632
Development and Use of Cognition Bolt-Ons for the EQ-5D-3L and EQ-5D-5L: A Systematic Review
Article Public 2026-07-17 2026-07-17
166 110.0659/CON.2026.00631
Strong Preferences or Simplifying Heuristics? Using Internal Validity Tests and Latent Class Analysis to Better Understand Stated Preference Survey Results. A Case Example in Health Preferences Research
Article Public 2026-07-17 2026-07-17
167 110.0658/CON.2026.00630
Who Needs Real Data Anyway? Exploring the Use of Synthetic Data in Economic Evaluations of Health Interventions
Article Public 2026-07-17 2026-07-17
168 110.0657/CON.2026.00629
Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation
Article Public 2026-07-17 2026-07-17
169 110.0656/CON.2026.00628
An Assessment of the Maturity of Cancer Survival Data Used in Economic Models for the National Institute for Health and Care Excellence’s Single Technology Appraisals
Article Public 2026-07-17 2026-07-17
170 110.0655/CON.2026.00627
Unravelling Public Preferences for the Use of Artificial Intelligence Mobile Health Applications in Australia
Article Public 2026-07-17 2026-07-17
171 110.0654/CON.2026.00626
Roles of Artificial Intelligence--Based Synthetic Data in Health Economics and Outcomes Research
Article Public 2026-07-17 2026-07-17
172 110.0653/CON.2026.00625
Generative Artificial Intelligence to Automate the Adaptation of Excel Health Economic Models and Word Technical Reports
Article Public 2026-07-17 2026-07-17
173 110.0652/CON.2026.00624
Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review
Article Public 2026-07-17 2026-07-17
174 110.0651/CON.2026.00623
The “Artificial Intelligence Statistician”: Utilizing Generative Artificial Intelligence to Select an Appropriate Model and Execute Network Meta-Analyses
Article Public 2026-07-17 2026-07-17
175 110.0650/CON.2026.00622
Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study
Article Public 2026-07-16 2026-07-17
176 110.0649/CON.2026.00621
Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study
Article Public 2026-07-16 2026-07-16
177 110.0648/CON.2026.00620
Artificial Intelligence in Health Economics and Outcomes Research: Highlighting the Contributions of Early Career Researchers
Article Public 2026-07-16 2026-07-16
178 110.0647/CON.2026.00619
Health Economics and Outcomes Research in the New Era of Artificial Intelligence: Catch Me If You Can
Article Public 2026-07-16 2026-07-16
179 110.0646/CON.2026.00618
ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group Report
Article Public 2026-07-16 2026-07-16
180 110.0645/CON.2026.00617
A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report
Article Public 2026-07-16 2026-07-16
181 110.0644/CON.2026.00616
Provider Differences in Costs, Utilization, and Quality of Primary Care for Traumatic Brain Injury in the Military
Article Public 2026-07-16 2026-07-16
182 110.0643/CON.2026.00615
Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics
Article Public 2026-07-16 2026-07-16
183 110.0642/CON.2026.00614
Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare
Article Public 2026-07-16 2026-07-16
184 110.0641/CON.2026.00613
Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States
Article Public 2026-07-16 2026-07-16
185 110.0640/CON.2026.00612
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
Article Public 2026-07-16 2026-07-16
186 110.0639/CON.2026.00611
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
Article Public 2026-07-16 2026-07-16
187 110.0638/CON.2026.00610
Cost per Opioid-Free Year: A Systematic Review and Summary Analysis
Article Public 2026-07-16 2026-07-16
188 110.0637/CON.2026.00609
Utility Studies in Rare Diseases: A Systematic Literature Review
Article Public 2026-07-16 2026-07-16
189 110.0636/CON.2026.00608
Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies
Article Public 2026-07-16 2026-07-16
190 110.0635/CON.2026.00607
Quality of Care for Patients With Advanced Illness Scale: Development, Preference Elicitation, and Evaluation of Measurement Properties
Article Public 2026-07-16 2026-07-16
191 110.0634/CON.2026.00606
Health State Utilities for Achondroplasia: A Time Trade-Off Study
Article Public 2026-07-16 2026-07-16
192 110.0633/CON.2026.00605
Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations
Article Public 2026-07-16 2026-07-16
193 110.0632/CON.2026.00604
Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives
Article Public 2026-07-16 2026-07-16
194 110.0631/CON.2026.00603
Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study
Article Public 2026-07-16 2026-07-16
195 110.0630/CON.2026.00602
Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study
Article Public 2026-07-16 2026-07-16
196 110.0629/CON.2026.00601
Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study
Article Public 2026-07-16 2026-07-16
197 110.0626/CON.2026.00600
Using Machine Learning to Match Clients and Therapy Providers: Evaluating Clinical Quality and Cost of Care
Article Public 2026-07-14 2026-07-16
198 110.0625/CON.2026.00599
The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands
Article Public 2026-07-14 2026-07-16
199 110.0624/CON.2026.00598
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare
Article Public 2026-07-14 2026-07-14
200 110.0623/CON.2026.00597
Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh Mental Wellbeing Scale, and World Health Organization Well-Being Index 5-Item
Article Public 2026-07-14 2026-07-14